Literature DB >> 26760198

Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies.

Christina Backes1, Farbod Sedaghat-Hamedani2,3,4, Karen Frese2,3,4, Martin Hart5, Nicole Ludwig5, Benjamin Meder2,3,4, Eckart Meese5, Andreas Keller1.   

Abstract

A certain degree of bias in high-throughput molecular technologies including microarrays and next-generation sequencing (NGS) is known. To quantify the actual impact of the biomarker discovery platform on miRNA profiles, we first performed a meta-analysis: raw data of 1 539 microarrays and 705 NGS blood-borne miRNomes were statistically evaluated, suggesting a substantial influence of the technology on biomarker profiles. We observed highly significant dependency of the miRNA nucleotide composition on the expression level. Higher expression in NGS was discovered for uracil-rich miRNAs (p = 7 × 10(-37)), while high expression in microarrays was found predominantly for guanine-rich miRNAs (p = 3 × 10(-33)). To verify the findings, 10 identical replicates of one individual were measured using NGS and microarrays (2 525 miRNAs from miRBase version 21). Overall, we calculated a correlation coefficient of 0.414 for both technologies. Detailed analysis however revealed that the correlation was observed only for miRNAs in the early miRBase versions (<8). The majority of miRNAs (2 013 from miRBase version 8 onward) was not correlated between microarray and NGS. Specifically, we observed 67 miRNAs with a median read count above 10 in NGS, while they were not detected in any of the 10 replicated array experiments. In contrast, 234 miRNAs were discovered in all 10 replicated array measurements but were not found in any of the NGS experiments of the same individual. While the first group had average guanine content of 22%, the latter group consisted of 41% of this nucleotide. Selected concordant and discordant miRNAs were tested in quantitative real-time-polymerase chain reaction (RT-qPCR) experiments again of the same individual, providing further evidence for the substantial bias depending on the base composition. As a consequence, biomarkers that have been discovered by specific high-throughout technologies have to be carefully considered. Especially for validation of the platform, the selection of reasonable candidates is essential.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26760198     DOI: 10.1021/acs.analchem.5b03376

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  26 in total

1.  miRSwitch: detecting microRNA arm shift and switch events.

Authors:  Fabian Kern; Jeremy Amand; Ilya Senatorov; Alina Isakova; Christina Backes; Eckart Meese; Andreas Keller; Tobias Fehlmann
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

2.  Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity.

Authors:  Tobias Fehlmann; Thomas Laufer; Christina Backes; Mustafa Kahramann; Julia Alles; Ulrike Fischer; Marie Minet; Nicole Ludwig; Fabian Kern; Tim Kehl; Valentina Galata; Aneta Düsterloh; Hannah Schrörs; Jochen Kohlhaas; Robert Bals; Hanno Huwer; Lars Geffers; Rejko Krüger; Rudi Balling; Hans-Peter Lenhof; Eckart Meese; Andreas Keller
Journal:  RNA Biol       Date:  2018-12-26       Impact factor: 4.652

3.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

Review 4.  Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.

Authors:  Christina Backes; Eckart Meese; Andreas Keller
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 5.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

6.  Web-based NGS data analysis using miRMaster: a large-scale meta-analysis of human miRNAs.

Authors:  Tobias Fehlmann; Christina Backes; Mustafa Kahraman; Jan Haas; Nicole Ludwig; Andreas E Posch; Maximilian L Würstle; Matthias Hübenthal; Andre Franke; Benjamin Meder; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

7.  Sources to variability in circulating human miRNA signatures.

Authors:  Andreas Keller; Trine Rounge; Christina Backes; Nicole Ludwig; Randi Gislefoss; Petra Leidinger; Hilde Langseth; Eckart Meese
Journal:  RNA Biol       Date:  2017-09-13       Impact factor: 4.652

Review 8.  The Importance of Standardization on Analyzing Circulating RNA.

Authors:  Inyoul Lee; David Baxter; Min Young Lee; Kelsey Scherler; Kai Wang
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

9.  Distribution of microRNA biomarker candidates in solid tissues and body fluids.

Authors:  Tobias Fehlmann; Nicole Ludwig; Christina Backes; Eckart Meese; Andreas Keller
Journal:  RNA Biol       Date:  2016-09-29       Impact factor: 4.652

10.  cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs.

Authors:  Tobias Fehlmann; Stefanie Reinheimer; Chunyu Geng; Xiaoshan Su; Snezana Drmanac; Andrei Alexeev; Chunyan Zhang; Christina Backes; Nicole Ludwig; Martin Hart; Dan An; Zhenzhen Zhu; Chongjun Xu; Ao Chen; Ming Ni; Jian Liu; Yuxiang Li; Matthew Poulter; Yongping Li; Cord Stähler; Radoje Drmanac; Xun Xu; Eckart Meese; Andreas Keller
Journal:  Clin Epigenetics       Date:  2016-11-21       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.